Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

Keyphrases

• Influenza 100%
• Vaccine Response 100%
• Frequency Response 100%
• Infection Frequency 100%
• Mortality Response 100%
• Morbidity Mortality 100%
• Immunosuppressed Population 100%
• Associated Complications 66%
• HIV Patients 33%
• Immunosuppression 33%
• Solid Organ Transplant 33%
• High-risk Population 33%
• High Risk 33%
• Vaccine Effectiveness 33%
• Chemotherapy 33%
• Influenza-like Illness 33%
• Longitudinal Data 33%
• Randomized Clinical Trial 33%
• Influenza Vaccination 33%
• Immunosuppressed 33%
• Clinical Trial Data 33%
• Influenza Prevention 33%
• Maintenance Hemodialysis Patients 33%
• Systemic Corticosteroids 33%
• General Trends 33%
• Haemopoietic Stem Cell Transplantation 33%
• Vaccination Recommendation 33%
• Influenza Incidence 33%
• Trial Data 33%

Medicine and Dentistry

• Infection 100%
• Human Immunodeficiency Virus 100%
• Health Care Cost 50%
• Hematopoietic Cell 50%
• Immunosuppressive Treatment 50%
• Stem Cell Transplant 50%
• Hemodialysis 50%
• High-Risk Population 50%
• Influenza Vaccination 50%
• Vaccine Efficacy 50%
• Randomized Clinical Trials 50%

Immunology and Microbiology

• Influenza 100%
• Infection 100%
• Human Immunodeficiency Virus 40%
• Vaccine Efficacy 20%
• Immunosuppression 20%
• Stem Cell Transplant 20%
• Population Risk 20%
• Hemodialysis 20%
• Hematopoietic Cell 20%